← all drugs
Rifampin Injection
in shortage · Anti-Infective · Snapshot: 2026-08-25
Day 2,015
of this shortage, counting from the FDA's first posting on 02/17/2021
- Manufacturers listed
- Fresenius Kabi USA, LLC, Sanofi-Aventis U.S. LLC, Mylan Institutional, a Viatris Company
- Reported reason(s)
- Delay in shipping of the drug; Discontinuation of the manufacture of the drug; Demand increase for the drug
- Machine-readable
- JSON for this drug
Presentations (4)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Rifampin, Injection, 600 mg (NDC 63323-351-20) | Fresenius Kabi USA, LLC | Unavailable | 08/04/2026 |
| Rifadin, Injection, 600 mg (NDC 0068-0597-01) | Sanofi-Aventis U.S. LLC | Unavailable | 06/22/2026 |
| Rifampin, Injection, 600 mg (NDC 67457-445-60) | Mylan Institutional, a Viatris Company | Unavailable | 08/20/2026 |
| Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01) | Sanofi-Aventis U.S. LLC | unknown | 04/20/2026 |
History
Daily change tracking began 2026-08-25 (index founding). Status flips and availability changes will accumulate here.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.